Skip to main content
Premium Trial:

Request an Annual Quote

Former Bayer Exec Fills CuraGen s New CMO Post

NEW YORK, Sept. 9 - CuraGen today said it has hired Bayer executive Tim Shannon to be its chief medical officer, a new position at the company.


Shannon, a physician and former senior vice present of global medical development at Bayer, will also be a senior vice president of R&D at CuraGen.


The new position was designed to help streamline CuraGen's move downstream. "We are translating our knowledge of the human genome into meaningful products. ...," CEO Jonathan Rothberg said in a statement. "The addition of Tim to our team increases the probability that we will do this in a timely and systematic fashion."


Click here for more information.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.